Hepatic impairment increased plasma concentrations of cyclobenzaprine. Use with caution in patients with mild hepatic impairment: start with cyclobenzaprine 5mg and titrate slowly upward.
Hypertension; monitor BP closely. Discontinue if signs/symptoms of liver disease develop, or if abnormal LFTs persist or worsen. Advanced renal disease: not recommended. Coagulation disorders.